Predicted to enable SH3 domain binding activity. Predicted to be located in nuclear membrane and nucleoplasm. Is expressed in brain. Orthologous to human SH3BGRL2 (SH3 domain binding glutamate rich protein like 2). [provided by Alliance of Genome Resources, Apr 2022]